Fairmount Funds Management LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
+81,552
(5.4%)
New positions
2
Sold out positions
2
Turnover %
46.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| KORSANA BIOSCIENCES INC | 291,319 | NEW |
| DAMORA THERAPEUTICS INC | 185,413 | NEW |
| VRDN | 11,302 | 12.1% |
| ZBIO | 4,084 | 6.8% |
| SNSE | 3,422 | 19.0% |
| CBIO | 3,081 | 6.2% |
| IKT | 215 | 1.2% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|